Cargando…
Is apoCIII-Lowering A Double-Edged Sword?
Autores principales: | Tang, Xiangming, Zhou, Huanjin, Yan, Haizhao, Niimi, Manabu, Fan, Jianglin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japan Atherosclerosis Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252641/ https://www.ncbi.nlm.nih.gov/pubmed/35545534 http://dx.doi.org/10.5551/jat.LE002 |
Ejemplares similares
-
Identification of the HDL-ApoCIII to VLDL-ApoCIII ratio as a predictor of coronary artery disease in the general population: The Chin-Shan Community Cardiovascular Cohort (CCCC) study in Taiwan
por: Chang, Po-Yuan, et al.
Publicado: (2012) -
The association of HDL-apoCIII with coronary heart disease and the effect of statin treatment on it
por: Xiong, Xiaowei, et al.
Publicado: (2015) -
ApoCIII enrichment in HDL impairs HDL-mediated cholesterol efflux capacity
por: Luo, Mengdie, et al.
Publicado: (2017) -
Effects of Fructose or Glucose on Circulating ApoCIII and Triglyceride and Cholesterol Content of Lipoprotein Subfractions in Humans
por: Hieronimus, Bettina, et al.
Publicado: (2019) -
Increased inflammation, endoplasmic reticulum stress and oxidative stress in endothelial and macrophage cells exacerbate atherosclerosis in ApoCIII transgenic mice
por: Yingchun, Han, et al.
Publicado: (2018)